Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RE-DUAL PCI Real Life Registry
NCT04688723Phase 4Unknown
- Sponsor
- Zuyderland
- Start
- Dec 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor in Atrial fibrillation (AFib), acute coronary syndrome (ACS), sponsored by Zuyderland. Status: unknown.
02
Drugs
ticagrelor
03
Conditions
Atrial fibrillation (AFib)acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT04688723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04688723.